Search

Your search keyword '"JEZIORSKI, ERIC"' showing total 355 results

Search Constraints

Start Over You searched for: Author "JEZIORSKI, ERIC" Remove constraint Author: "JEZIORSKI, ERIC"
355 results on '"JEZIORSKI, ERIC"'

Search Results

51. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

52. Guidelines for cold urticaria management established by the Centre of Evidence of Dermatology and the Urticaria Group of the French Society of Dermatology.

53. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation

55. An appraisal of the frequency and severity of noninfectious manifestations in primary immunodeficiencies: A study of a national retrospective cohort of 1375 patients over 10 years

56. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

57. Case Report: Persistency Pneumococcal Polysaccharide in Cerebrospinal Fluid During a Post Pneumococcal Chronic Aseptic Meningitis: Coincidental or (Auto-)Inflammatory Embers

63. Pediatric-Onset Evans Syndrome Is Associated with Broad Immunopathological Manifestations, High Treatment Burden and Mortality in Long-Term Follow-up

64. When Familial Hearing Loss Means Genetic Heterogeneity: A Model Case Report

65. Hematological Involvement in Childhood Langerhans Cell Histiocytosis: A Cohort Study of 303 Patients

66. Correction to: A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency

67. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis

69. Thymus and mediastinal node involvement in childhood langerhans cell histiocytosis: Long-term follow-up from the French national cohort

70. Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden

72. Genetic diagnosis of primary immunodeficiencies: A survey of the French national registry

73. Impact and Dynamics of TP53 Mutated Clones in Shwachman Diamond Syndrome in a Series of 80 Patients

74. Corrigendum to: Diagnostic Yield of Next-Generation Sequencing in Very Early-Onset Inflammatory Bowel Diseases: A Multicenter Study

76. Differential Accumulation and Activation of Monocyte and Dendritic Cell Subsets in Inflamed Synovial Fluid Discriminates Between Juvenile Idiopathic Arthritis and Septic Arthritis

77. Long‐term follow‐up of children with risk organ‐negative Langerhans cell histiocytosis after 2‐chlorodeoxyadenosine treatment

78. Clinical, functional and genetic characterization of Sixteen Patients Suffering from Chronic Granulomatous Disease variants - Identification of Twelve Novel Mutations in CYBB

80. Additional file 1 of The French paediatric cohort of Castleman disease: a retrospective report of 23 patients

81. Additional file 2 of The French paediatric cohort of Castleman disease: a retrospective report of 23 patients

83. Diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: A multicentre study

84. KI and WU Polyomaviruses in children, France

85. Evaluation of Post-Infectious Inflammatory Reactions in a Retrospective Study for Three Common Invasive Bacterial Infections in Pediatrics

86. Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis

87. Alemtuzumab as First Line Treatment in Children with Familial Lymphohistiocytosis

89. SAT0488 THE FRENCH PAEDIATRIC COHORT OF CASTLEMAN DISEASE

90. Genetic diagnosis of primary immunodeficiencies: A survey of the French national registry

91. No evidence for XMRV association in pediatric idiopathic diseases in France

92. Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

93. Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children

94. Second‐line treatment trends and long‐term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years.

95. Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study

96. Treatment with cyclosporin in auto‐immune cytopenias in children: The experience from the French cohort OBS'CEREVANCE

98. Torticollis in Children

100. Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance

Catalog

Books, media, physical & digital resources